Madrigal Pharmaceuticals, Inc.

NasdaqGS:MDGL Stock Report

Market Cap: US$6.8b

Madrigal Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:MDGL Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
03 Dec 24SellUS$1,135,122The Craves Family Foundation., Endowment ArmCompany3,600US$315.90
25 Nov 24SellUS$1,191,028The Craves Family Foundation., Endowment ArmCompany3,400US$350.71
21 Nov 24SellUS$218,041Carole HuntsmanIndividual688US$316.92
09 Sep 24SellUS$1,551,490William SiboldIndividual6,363US$243.83
21 May 24SellUS$239,668Robert WaltermireIndividual1,036US$231.34

Insider Trading Volume

Insider Buying: MDGL insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of MDGL?
Owner TypeNumber of SharesOwnership Percentage
Private Companies836,7273.19%
Individual Insiders2,445,4209.31%
Hedge Funds8,039,27730.6%
Institutions14,945,18056.9%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 10.5%.

Top Shareholders

Top 25 shareholders own 99.81% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.4%
Janus Henderson Group plc
2,478,160US$775.9m-0.31%0.31%
9.36%
Paulson & Co. Inc.
2,042,000US$639.4m10.4%24.27%
9.3%
Avoro Capital Advisors LLC
2,029,000US$635.3m-1.29%8.91%
9.14%
RTW Investments, LP
1,993,687US$624.2m4.06%9.07%
9.05%
Baker Bros. Advisors LP
1,974,590US$618.3m0%6.16%
8.41%
The Vanguard Group, Inc.
1,833,768US$574.2m1.5%0.01%
6.7%
BlackRock, Inc.
1,461,386US$457.6m2.39%0.01%
5%
Rebecca Taub
1,089,802US$341.2m0%no data
4.35%
Paul Friedman
948,639US$297.0m0%no data
4.07%
State Street Global Advisors, Inc.
887,752US$278.0m19.2%0.01%
3.59%
FMR LLC
783,513US$245.3m-0.69%0.01%
3.36%
T. Rowe Price Group, Inc.
733,697US$229.7m-17%0.02%
3.01%
SQN, LLC
655,540US$205.3m0%no data
1.86%
Geode Capital Management, LLC
405,655US$127.0m1.45%0.01%
1.7%
Frederick Craves
370,572US$116.0m0%no data
1.41%
Artisan Partners Limited Partnership
306,846US$96.1m-11.1%0.07%
1.21%
Rock Springs Capital Management LP
263,062US$82.4m7.15%2.81%
1.11%
Morgan Stanley, Investment Banking and Brokerage Investments
242,775US$76.0m24.4%0.01%
1.07%
Erste Asset Management GmbH
234,400US$73.4m-4.47%0.57%
0.93%
UBS Asset Management AG
202,986US$63.6m2.6%0.01%
0.84%
Braidwell LP
183,818US$57.6m0%2.59%
0.83%
667, L.P.
181,187US$56.7m0%no data
0.74%
ArrowMark Colorado Holdings, LLC
161,952US$50.7m-13.6%0.64%
0.7%
Goldman Sachs Group, Investment Banking and Securities Investments
152,855US$47.9m41.7%0.02%
0.69%
Pictet Asset Management Limited
150,598US$47.2m9.71%0.04%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/30 01:57
End of Day Share Price 2024/12/30 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Madrigal Pharmaceuticals, Inc. is covered by 22 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Matthew LuchiniBMO Capital Markets Equity Research
Jason ZemanskyBofA Global Research
Alexandria HammondBofA Global Research